Table 3.
At 3 months | At 6 months | |||
---|---|---|---|---|
Parameter estimate (SE) | p valuea | Parameter estimate (SE) | p valuea | |
SFA | ||||
Myristic acid 14:0 | − 0.11 (0.02) | < 0.0001 | 0.03 (0.02) | 0.090 |
Pentadecanoic acid 15:0 | 0.21 (0.02) | < 0.0001 | 0.22 (0.02) | < 0.0001 |
Palmitic acid 16:0 | − 0.25 (0.01) | < 0.0001 | − 0.19 (0.01) | < 0.0001 |
Heptadecanoic acid 17:0 | 0.09 (0.02) | < 0.0001 | 0.14 (0.01) | < 0.0001 |
iso − heptadecanoic acid i17:0 | 0.91 (0.03) | < 0.0001 | 0.78 (0.03) | < 0.0001 |
Stearic acid 18:0 | − 0.12 (0.01) | < 0.0001 | − 0.09 (0.01) | < 0.0001 |
Eicosanoid acid 20:0 | − 0.29 (0.02) | < 0.0001 | − 0.24 (0.02) | < 0.0001 |
Docosanoic acid 22:0 | − 0.18 (0.02) | < 0.0001 | − 0.14 (0.02) | < 0.0001 |
Tetracosanic acid 24:0 | − 0.22 (0.02) | < 0.0001 | − 0.18 (0.02) | < 0.0001 |
MUFA | ||||
Palmitoleic acid 16:1n − 7 | 0.34 (0.03) | < 0.0001 | 0.22 (0.02) | < 0.0001 |
Cis vaccenic acid 18:1n − 7 | 0.10 (0.01) | < 0.0001 | 0.06 (0.01) | < 0.0001 |
Oleic acid 18:1n − 9 | − 0.25 (0.01) | < 0.0001 | − 0.21 (0.01) | < 0.0001 |
11 − eicosenoic acid 20:1n − 9 | − 0.32 (0.03) | < 0.0001 | − 0.32 (0.02) | < 0.0001 |
Nervonic acid 24:1n − 9 | − 0.34 (0.02) | < 0.0001 | − 0.28 (0.02) | < 0.0001 |
n − 6 PUFA | ||||
LA 18:2n − 6 | − 0.34 (0.02) | < 0.0001 | − 0.28 (0.01) | < 0.0001 |
DGLA 20:3n − 6 | − 0.04 (0.02) | 0.042 | − 0.09 (0.02) | < 0.0001 |
AA 20:4n − 6 | − 0.08 (0.02) | < 0.0001 | − 0.11 (0.01) | < 0.0001 |
Adrenic acid 22:4n − 6 | − 0.26 (0.02) | < 0.0001 | − 0.29 (0.02) | < 0.0001 |
n − 3 PUFA | ||||
ALA 18:3n − 3 | − 0.37 (0.03) | < 0.0001 | − 0.34 (0.02) | < 0.0001 |
EPA 20:5n − 3 | 0.57 (0.05) | < 0.0001 | 0.48 (0.04) | < 0.0001 |
DPA 22:5n − 3 | 0.31 (0.02) | < 0.0001 | 0.32 (0.02) | < 0.0001 |
DHA 22:6n − 3 | 0.03 (0.02) | 0.118 | − 0.01 (0.02) | 0.679 |
Other | ||||
CLA 18:2n − 7 ct/tc10,12 | 0.82 (0.04) | < 0.0001 | 0.73 (0.03) | < 0.0001 |
DMA16 | − 0.16 (0.01) | < 0.0001 | − 0.16 (0.01) | < 0.0001 |
DMA18 | − 0.06 (0.01) | < 0.0001 | − 0.06 (0.01) | < 0.0001 |
Ratio n − 6:n − 3 PUFA | − 1.36 (0.12) | < 0.0001 | − 1.09 (0.07) | < 0.0001 |
aThe difference between fatty acid status of breastfed and not breastfed children at the age of 3 and 6 month was tested by fitting a linear regression model for CLR transformed fatty acid (except for the ratio of sum n − 6 and sum n − 3), adjusted for case–control status.